CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $139,463 | -40.4% | 7,498 | -58.8% | 0.01% | -50.0% |
| Q3 2022 | $234,000 | -28.7% | 18,202 | -61.1% | 0.01% | -6.7% |
| Q2 2022 | $328,000 | -15.5% | 46,759 | 0.0% | 0.02% | -6.2% |
| Q1 2022 | $388,000 | +12.5% | 46,759 | -8.1% | 0.02% | +33.3% |
| Q4 2021 | $345,000 | -8.5% | 50,895 | -28.5% | 0.01% | 0.0% |
| Q3 2021 | $377,000 | -19.3% | 71,187 | -12.4% | 0.01% | +9.1% |
| Q2 2021 | $467,000 | +24.5% | 81,249 | 0.0% | 0.01% | +22.2% |
| Q1 2021 | $375,000 | +14.7% | 81,249 | -17.0% | 0.01% | +28.6% |
| Q4 2020 | $327,000 | +4.5% | 97,912 | -6.9% | 0.01% | 0.0% |
| Q3 2020 | $313,000 | – | 105,219 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |